Journal Article DZNE-2025-01261

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
An unsupervised XAI framework for dementia detection with context enrichment.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2025
Springer Nature [London]

Scientific reports 15(1), 39554 () [10.1038/s41598-025-26227-2]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Explainable Artificial Intelligence (XAI) methods enhance the diagnostic efficiency of clinical decision support systems by making the predictions of a convolutional neural network's (CNN) on brain imaging more transparent and trustworthy. However, their clinical adoption is limited due to limited validation of the explanation quality. Our study introduces a framework that evaluates XAI methods by integrating neuroanatomical morphological features with CNN-generated relevance maps for disease classification. We trained a CNN using brain MRI scans from six cohorts: ADNI, AIBL, DELCODE, DESCRIBE, EDSD, and NIFD (N = 3253), including participants that were cognitively normal, with amnestic mild cognitive impairment, dementia due to Alzheimer's disease and frontotemporal dementia. Clustering analysis benchmarked different explanation space configurations by using morphological features as proxy-ground truth. We implemented three post-hoc explanations methods: (i) by simplifying model decisions, (ii) explanation-by-example, and (iii) textual explanations. A qualitative evaluation by clinicians (N = 6) was performed to assess their clinical validity. Clustering performance improved in morphology enriched explanation spaces, improving both homogeneity and completeness of the clusters. Post hoc explanations by model simplification largely delineated converters and stable participants, while explanation-by-example presented possible cognition trajectories. Textual explanations gave rule-based summarization of pathological findings. Clinicians' qualitative evaluation highlighted challenges and opportunities of XAI for different clinical applications. Our study refines XAI explanation spaces and applies various approaches for generating explanations. Within the context of AI-based decision support system in dementia research we found the explanations methods to be promising towards enhancing diagnostic efficiency, backed up by the clinical assessments.

Keyword(s): Humans (MeSH) ; Dementia: diagnosis (MeSH) ; Dementia: diagnostic imaging (MeSH) ; Magnetic Resonance Imaging: methods (MeSH) ; Male (MeSH) ; Female (MeSH) ; Aged (MeSH) ; Cognitive Dysfunction: diagnostic imaging (MeSH) ; Cognitive Dysfunction: diagnosis (MeSH) ; Alzheimer Disease: diagnostic imaging (MeSH) ; Alzheimer Disease: diagnosis (MeSH) ; Neural Networks, Computer (MeSH) ; Artificial Intelligence (MeSH) ; Brain: diagnostic imaging (MeSH) ; Brain: pathology (MeSH) ; Aged, 80 and over (MeSH) ; Alzheimer’s disease ; Brain volumetry ; Explainable artificial intelligence (XAI) ; Frontotemporal dementia ; Magnetic resonance imaging ; Neurodegenerative diseases ; Qualitative evaluation

Classification:

Contributing Institute(s):
  1. Clinical Dementia Research (Rostock /Greifswald) (AG Teipel)
  2. Translational Neurodegeneration (AG Hermann)
  3. Clinical Research (Munich) (Clinical Research (Munich))
  4. Clinical Neurophysiology and Memory (AG Düzel)
  5. Patient Studies (Bonn) (Patient Studies (Bonn))
  6. Biomarker-Assisted Early Detection of Dementias (AG Peters)
  7. Clinical Research Coordination (Clinical Research (Bonn))
  8. Parkinson Genetics (AG Gasser)
  9. Vascular Cognitive Impairment & Post-Stroke Dementia (AG Dichgans)
  10. Translational Neuropsychiatry (AG Priller)
  11. Clinical Research Platform (CRP) (AG Spottke)
  12. Translational Dementia Research (Bonn) (AG Schneider)
  13. Epigenetics and Systems Medicine in Neurodegenerative Diseases (AG Fischer)
  14. Molecular biomarkers for predictive diagnostics of neurodegenerative diseases (AG Wiltfang)
  15. Clinical Alzheimer’s Disease Research (AG Jessen)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
  2. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Database coverage:
Medline ; DOAJ ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-Clinical Research (Bonn)
Institute Collections > M DZNE > M DZNE-Clinical Research (Munich)
Institute Collections > BN DZNE > BN DZNE-Patient Studies (Bonn)
Document types > Articles > Journal Article
Institute Collections > GÖ DZNE > GÖ DZNE-AG Wiltfang
Institute Collections > BN DZNE > BN DZNE-AG Schneider
Institute Collections > GÖ DZNE > GÖ DZNE-AG Fischer
Institute Collections > ROS DZNE > ROS DZNE-AG Hermann
Institute Collections > ROS DZNE > ROS DZNE-AG Teipel
Institute Collections > TÜ DZNE > TÜ DZNE-AG Gasser
Institute Collections > BN DZNE > BN DZNE-AG Spottke
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Institute Collections > MD DZNE > MD DZNE-AG Düzel
Institute Collections > M DZNE > M DZNE-AG Dichgans
Institute Collections > B DZNE > B DZNE-AG Priller
Institute Collections > B DZNE > B DZNE-AG Peters
Documents in Process
Public records

 Record created 2025-11-14, last modified 2025-11-14


Restricted:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)